csirt@kutim:~/threat-intel/cve/CVE-2026-89559

Katalog CVE

CVSS 7.8 · High EPSS 0,17%

Skor CVSS 3.1 7.8 (High) menurut CNA.

Deskripsi (NVD)

In the Linux kernel, the following vulnerability has been resolved: libnvdimm/labels: Prevent integer overflow in __nd_label_validate() The on-media namespace index field nslot is a u32 read from the DIMM label storage area. __nd_label_validate() bounds it against the config area size, but sizeof_namespace_label() returns unsigned, so the product nslot * label_size is evaluated in 32-bit and wraps modulo 2^32 before the comparison. A crafted nslot passes the bound and is then used as the loop trip count in nd_label_data_init(), whose memset() walks off the end of the config_size buffer: an out-of-bounds write. The field is not trusted -- it comes from the medium, or from userspace via ND_CMD_SET_CONFIG_DATA. Evaluate the product in 64-bit so the bound check is exact; conforming labels are unaffected. The check was safe when introduced by commit 4a826c83db4e ("libnvdimm: namespace indices: read and validate"): it multiplied by sizeof(struct nd_namespace_label), a size_t, so on a 64-bit build the product did not wrap. Commit 564e871aa66f ("libnvdimm, label: add v1.2 nvdimm label definitions") narrowed it to 32 bits when the label size became a runtime value read via sizeof_namespace_label().

Rincian

Terbit di NVD
11 September 2026
Terakhir diubah
14 September 2026
Status NVD
Received
CVSS 3.1
7.8 (High), sumber CNA
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H · uraikan di kalkulator
EPSS (30 hari)
0,17% peluang dieksploitasi; lebih tinggi dari 5,7% CVE lain

Produk dan versi terdampak

NVD belum mencantumkan data produk (CPE) untuk CVE ini. Produk yang terdampak biasanya disebut di deskripsi dan di advisory vendor pada daftar referensi.

Referensi dan perbaikan

Sumber: NVD · CVE.org · EPSS. Halaman ini disusun otomatis dari data tersebut; pembaruan terakhir 5 Okt 2026, 20:11 WITA. Kalau sistem di Perangkat Daerah memakai produk ini dan butuh bantuan, laporkan lewat kanal pelaporan.